Commentary · 21 Feb 2026
Conference abstractPublished 15 Aug 2011
Detection and quantification of circulating melanoma cells in patients with cutaneous malignant melanoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our research is aimed at detection, characterisation and quantification of circulating melanoma cells in patients with Cutaneous Malignant Melanoma. This research will assist with development of a prognostic blood test for the detection of melanoma micrometastases in patients before and after surgery and during therapy to assess efficacy. To date we have used qRT-PCR to assess circulating melanoma cells in 300 melanoma patients and 100 healthy volunteers. The frequency and level of expression of markers was correlated to Breslow tumour thickness and tumour progression and results were statistically analysed. Control blood samples spiked with cells from metastatic melanoma cell lines were used as positive controls. Antibodies to melanoma cell markers have also been used in flow cytometry and immunomagnetic bead capture experiments to isolate circulating cells from patient blood samples. Our results clearly demonstrate the presence of circulating melanoma cells in 79% of patients with stage III and IV disease whilst these markers were observed in only 20-30% of early stage patients. Assay sensitivity tests showed that markers can be detected from as few as 5 cells per blood sample. Surprisingly, melanoma cells are found in peripheral blood of patients with early stage tumours and in patients from whom tumours were removed several years previously. Using immunomagnetic bead capture we have quantified the circulating cells in patient blood and found that cell number correlates with disease stage particularly when specific cell surface markers are used to isolate cells. Further research will clarify the molecular signature of metastatic circulating melanoma cells.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “M Ziman”
- BylineArticles whose byline prints “M. Millward”
- BylineArticles whose byline prints “R. Pearce”
- BylineArticles whose byline prints “M. Lee”
- BylineArticles whose byline prints “P. Kumarasinghe”
- BylineArticles whose byline prints “A. Irel”
